Results 1 to 10 of about 53,297 (154)

α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP.

open access: yesPLoS ONE, 2017
α-Synuclein misfolding and aggregation is often accompanied by β-amyloid deposition in some neurodegenerative diseases. We hypothesised that α-synuclein promotes β-amyloid production from APP.
Hazel L Roberts   +2 more
doaj   +1 more source

Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice

open access: yesNeurobiology of Disease, 2014
Several lines of evidence suggest that accumulation of aggregated alpha-synuclein (α-synuclein) in the central nervous system (CNS) is an early pathogenic event in Parkinson's disease and other Lewy body disorders.
Veronica Lindström   +14 more
doaj   +1 more source

Polo-like kinase 2 modulates α-synuclein protein levels by regulating its mRNA production

open access: yesNeurobiology of Disease, 2017
Variations in the α-synuclein-encoding SNCA gene represent the greatest genetic risk factor for Parkinson's disease (PD), and duplications/triplications of SNCA cause autosomal dominant familial PD.
Rikke H. Kofoed   +9 more
doaj   +1 more source

Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients

open access: yesActa Neuropathologica Communications, 2018
In Parkinson’s disease (PD) there is widespread accumulation in the brain of abnormal α-synuclein aggregates forming intraneuronal Lewy bodies (LB). It is now well established that LB-type α-synuclein aggregates also occur in the peripheral autonomic ...
Ariadna Recasens   +6 more
doaj   +1 more source

Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human α-synuclein

open access: yesActa Neuropathologica Communications, 2019
Glial cytoplasmic inclusions (GCIs) containing aggregated and hyperphosphorylated α-synuclein are the signature neuropathological hallmark of multiple system atrophy (MSA).
Zuzana Krejciova   +3 more
doaj   +1 more source

Elevated plasma levels of alpha-synuclein are dispensable for Parkinson’s disease pathology

open access: yesnpj Parkinson's Disease
Although α-synuclein levels are elevated in the blood plasma of Parkinson’s disease (PD) patients, it remains unclear whether blood-derived α-synuclein directly contributes to PD.
Jin-Young Jeong   +5 more
doaj   +1 more source

Host-to-graft propagation of inoculated α-synuclein into transplanted human induced pluripotent stem cell-derived midbrain dopaminergic neurons

open access: yesRegenerative Therapy
Introduction: Cell therapeutic clinical trials using fetal mesencephalic tissue provided a proof-of-concept for regenerative therapy in patients with Parkinson's disease.
Serina Gima   +7 more
doaj   +1 more source

Elevated α-synuclein levels inhibit mitophagic flux

open access: yesnpj Parkinson's Disease
The pathogenic effect of SNCA gene multiplications indicates that elevation of wild-type α-synuclein levels is sufficient to cause Parkinson’s disease (PD). Mitochondria have been proposed to be a major target of α-synuclein-induced damage.
Inge Kinnart   +8 more
doaj   +1 more source

Intracellular Catalytic Photooxygenation of α‐Synuclein Amyloid

open access: yesChemistryEurope
The amyloid aggregation of α‐synuclein is a central pathological hallmark of various synucleinopathies, including Parkinson disease. Consequently, developing strategies to eliminate α‐synuclein amyloids represents a promising therapeutic approach.
Atsushi Iwai   +11 more
doaj   +1 more source

Recruitment of Aβ into α‑Synuclein Condensates Catalyzes Primary Nucleation of α‑Synuclein Aggregation

open access: yesACS Central Science
Owen M. Morris   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy